Maja V.
- Country
- Denmark
- Department
- #208001: Blodsygdomme Klinisk Forskning
Research Overview
- Evaluation of Safety, Tolerability, and Clinical Activity of Forimtamig-Based Combinations in Relapsed or Refractory Multiple Myeloma Patients
- Phase 3 Open-Label Study of Elranatamab vs. Elotuzumab, Pomalidomide, Dexamethasone, or Carfilzomib in Relapsed/Refractory Multiple Myeloma Post Anti-CD38 Therapy
- A Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-Tec), and Investigator’s Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants with Relapsed or Refractory Myeloma who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide
Data & Insights
Has run more than one trial at 126 of 288 partner sites.
Specializations
Multiple Myeloma Research
The investigator specializes in studying advanced treatments for multiple myeloma, with particular focus on both newly diagnosed cases and relapsed/refractory conditions.
- Novel Therapeutic Combinations
- Treatment-Resistant Myeloma
- First-Line Therapy Approaches
Expertise includes evaluating innovative immunotherapy approaches and combination strategies for enhancing treatment outcomes.
Immunotherapy Innovation
The investigator focuses on pioneering immunotherapeutic approaches including CAR T-cell therapy and monoclonal antibodies for hematologic malignancies.
- CAR T-Cell Therapy Development
- Monoclonal Antibody Treatments
- Targeted Therapy Combinations
Special interest in developing personalized immunotherapy strategies for treating resistant disease forms.
Rare Blood Disorders
Research extends to rare hematologic conditions, including AL Amyloidosis and related plasma cell disorders.
- Systemic AL Amyloidosis Treatment
- Novel Drug Combinations
- Early Disease Intervention
Expertise in developing treatment protocols for newly diagnosed rare blood disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
